<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>OBJECTIVE: A number of studies have shown an inverse association between <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> with Helicobacter pylori and oesophageal <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> (OAC) </plain></SENT>
<SENT sid="1" pm="."><plain>The mechanism of the apparent protection against OAC by <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> and, in particular, the role of gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath> is disputed </plain></SENT>
<SENT sid="2" pm="."><plain>The relationship between <z:hpo ids='HP_0000001'>all</z:hpo> stages of the oesophageal <z:mp ids='MP_0001845'>inflammation</z:mp>, <z:mpath ids='MPATH_160'>metaplasia</z:mpath>, <z:mp ids='MP_0009308'>adenocarcinoma</z:mp> sequence and <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> and gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath> was explored </plain></SENT>
<SENT sid="3" pm="."><plain>METHODS: A case-control study involving 260 population controls, 227 OAC, 224 Barrett's oesophagus (BO) and 230 reflux <z:e sem="disease" ids="C0014868" disease_type="Disease or Syndrome" abbrv="">oesophagitis</z:e> (RO) patients recruited within Ireland was carried out </plain></SENT>
<SENT sid="4" pm="."><plain>H pylori and CagA (cytotoxin-associated gene product A) <z:e sem="disease" ids="C0021311,C0009450" disease_type="Disease or Syndrome" abbrv="">infection</z:e> was diagnosed serologically by western blot, and pepsinogen I and II levels were measured by enzyme immunoassay </plain></SENT>
<SENT sid="5" pm="."><plain>Gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath> was defined as a pepsinogen I/II ratio of &lt;3 </plain></SENT>
<SENT sid="6" pm="."><plain>RESULTS: H pylori seropositivity was inversely associated with OAC, BO and RO; adjusted ORs (95% CIs), 0.49 (0.31 to 0.76), 0.35 (0.22 to 0.56) and 0.42 (0.27 to 0.65), respectively </plain></SENT>
<SENT sid="7" pm="."><plain>Gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath> was uncommon (5.3% of <z:hpo ids='HP_0000001'>all</z:hpo> subjects), but was inversely associated with non-junctional OAC, BO and RO; adjusted ORs (95% CIs), 0.34 (0.10 to 1.24), 0.23 (0.05 to 0.96) and 0.27 (0.08 to 0.88), respectively </plain></SENT>
<SENT sid="8" pm="."><plain>Inverse associations between H pylori and the <z:mp ids='MP_0002054'>disease states</z:mp> remained in gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath>-negative patients </plain></SENT>
<SENT sid="9" pm="."><plain>CONCLUSION: <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> and gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath> are associated with a reduced risk of OAC, BO and RO </plain></SENT>
<SENT sid="10" pm="."><plain>While use of the pepsinogen I/II ratio as a marker for gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath> has limitations, these data suggest that although gastric <z:mpath ids='MPATH_127'>atrophy</z:mpath> is involved it may not fully explain the inverse associations observed with <z:e sem="disease" ids="C0850666" disease_type="Disease or Syndrome" abbrv="">H pylori infection</z:e> </plain></SENT>
</text></document>